Abbott Vascular Inc. - Product Pipeline Analysis, 2015 Update

Date: July 22, 2015
Pages: 53
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ABB9003FE97EN
Leaflet:

Download PDF Leaflet

Abbott Vascular Inc. - Product Pipeline Analysis, 2015 Update
Summary

Abbott Vascular Inc. (Abbott Vascular), a subsidiary of Abbott Laboratories is a medical device company that research, develops, manufactures, and markets therapeutic solutions for the treatment of cardiac and vascular diseases.The company offers coronary intervention products including bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires and othersperipheral intervention products including peripheral dilatation catheters, peripheral guide wires and peripheral stent systemsand others. The company also offers vessel closure products including clip closure, suture-mediated closure and vessel closure accessoriesand others. Abbott Vascular is headquartered in Santa Clara, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Abbott Vascular Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Abbott Vascular Inc. Company Snapshot
Abbott Vascular Inc. Company Overview
Key Information
Abbott Vascular Inc. Pipeline Products and Clinical Trials Overview
Abbott Vascular Inc. – Pipeline Analysis Overview
Key Facts
Abbott Vascular Inc. - Major Products and Services
Abbott Vascular Inc. Pipeline Products by Development Stage
Abbott Vascular Inc. Clinical Trials by Trial Status
Abbott Vascular Inc. Pipeline Products Overview
Absorb Bioresorbable Vascular Scaffold
Absorb Bioresorbable Vascular Scaffold Product Overview
Absorb Bioresorbable Vascular Scaffold Clinical Trial
AVJ-09-385 Everolimus Eluting Coronary Stent System
AVJ-09-385 Everolimus Eluting Coronary Stent System Product Overview
AVJ-09-385 Everolimus Eluting Coronary Stent System Clinical Trial
Chemical RDN System
Chemical RDN System Product Overview
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5)
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) Product Overview
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) Clinical Trial
ESPRIT Bioresorbable Vascular Scaffold
ESPRIT Bioresorbable Vascular Scaffold Product Overview
ESPRIT Bioresorbable Vascular Scaffold Clinical Trial
Next Generation Mitral Regurgitation System
Next Generation Mitral Regurgitation System Product Overview
Next Generation SUPERA Delivery System
Next Generation SUPERA Delivery System Product Overview
Xience SBA Everolimus Eluting Coronary Stent System
Xience SBA Everolimus Eluting Coronary Stent System Product Overview
XIENCE Thinman DES
XIENCE Thinman DES Product Overview
ZoMaxx Drug Eluting Coronary Stent System
ZoMaxx Drug Eluting Coronary Stent System Product Overview
Abbott Vascular Inc. - Key Competitors
Abbott Vascular Inc. - Key Employees
Abbott Vascular Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Abbott Vascular Inc., Recent Developments
Jul 20, 2015: John Muir Health Among First Hospitals in Northern California to Offer Breakthrough Device for Patients with Debilitating Heart Valve Disease
May 19, 2015: Abbott Announces CE Mark For New Advancement Of Absorb Stent System For People With Heart Disease
Mar 18, 2015: Cooper Heart Institute Participating in Study of New Heart Valve Treatment
Mar 15, 2015: Abbott's MitraClip System Shown to Mend Hearts and Improve Lives in People in the United States
Feb 02, 2015: ISET 2015: Minimally Invasive Clip Can Repair Mitral Valve Regurgitation
Oct 20, 2014: Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair
Sep 24, 2014: Heart Hospital of Austin First in Central Texas To Implant MitraClip, a Minimally Invasive Treatment Option for Mitral Valve Disease
Sep 22, 2014: Abbott Vascular To Shut Down Manufacturing Facility In Webster, Texas
Sep 15, 2014: Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device
Sep 14, 2014: ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Abbott Vascular Inc., Key Facts
Abbott Vascular Inc. Pipeline Products and Clinical Trials Overview
Abbott Vascular Inc. Pipeline Products by Equipment Type
Abbott Vascular Inc. Pipeline Products by Indication
Abbott Vascular Inc. Clinical Trials by Trial Status
Abbott Vascular Inc., Key Facts
Abbott Vascular Inc., Major Products and Services
Abbott Vascular Inc. Number of Pipeline Products by Development Stage
Abbott Vascular Inc. Pipeline Products Summary by Development Stage
Abbott Vascular Inc. Clinical Trials by Trial Status
Abbott Vascular Inc. Clinical Trials Summary
Absorb Bioresorbable Vascular Scaffold - Product Status
Absorb Bioresorbable Vascular Scaffold - Product Description
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects with de Novo Native Coronary Artery Lesions in Chinese Population
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, The Everolimus Eluting Bioresorbable Vascular Scaffold In The Treatment Of Subjects With De Novo Native Coronary Artery Lesions
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of AVJ-301 (Absorb BVS), The Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions in Japanese Population
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation to Compare the Safety, Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System Against XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Subjects with Ischemic Heart Disease Caused by de Novo Native Coronary Artery Lesions: ABSORB II Randomized Controlled Trial
Absorb Bioresorbable Vascular Scaffold - A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions: ABSORB EXTEND Clinical Investigation
Absorb Bioresorbable Vascular Scaffold - A Multicentre Prospective Natural History Study Using Multimodality Imaging in Patients with Acute Coronary Syndromes - PROSPECT II (Natural History Study) Combined with a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial)
Absorb Bioresorbable Vascular Scaffold - A Post-market Registry of Patients with de Novo Lesions in Previously Untreated Vessels Treated with Absorb BVS
Absorb Bioresorbable Vascular Scaffold - A Prospective, Randomized Trial of SYNERGY Bioresorbable Polymer Coated Stents Versus Absorb Bioresorbable Backbone Stents in Patients Undergoing Coronary Stenting (ISAR-RESORB)
Absorb Bioresorbable Vascular Scaffold - A Randomized Controlled Comparison of Optical Coherence Tomography Guidance and Angiography-only Guidance for Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffold
Absorb Bioresorbable Vascular Scaffold - ABSORB Bioresorbable Scaffold versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis
Absorb Bioresorbable Vascular Scaffold - Absorb Bioresorbable Scaffold Vs. Drug Coated Balloon for Treatment of In-stent-restenosis
Absorb Bioresorbable Vascular Scaffold - Amsterdam Investigator-initiated Absorb Strategy All-comers Trial (AIDA Trial): A Clinical Evaluation Comparing the Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold Strategy Versus the XIENCE Family (XIENCE PRIME or XIENCE Xpedition) Everolimus Eluting Coronary Stent Strategy in the Treatment of Coronary Lesions in Consecutive All-comers
Absorb Bioresorbable Vascular Scaffold - An International Post-market Registry of Patients With de Novo Lesions in Previously Untreated Vessels Treated With Absorb Bioresorbable Vascular Scaffold (Absorb BVS): ABSORB FIRST Registry
Absorb Bioresorbable Vascular Scaffold - Comparison of the ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (Xience) in Acute ST-Elevation Myocardial Infarction
Absorb Bioresorbable Vascular Scaffold - Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms: a Multi-modality, Multi-specialty Collaborative Study (PERFECT Program)
Absorb Bioresorbable Vascular Scaffold - Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study
Absorb Bioresorbable Vascular Scaffold - German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Absorb Bioresorbable Vascular Scaffold - Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion: A Randomized H215O PET/CT Study
Absorb Bioresorbable Vascular Scaffold - Optimal Lesion Preparation with Non-compliant Balloons for the Implantation of Bioresorbable Vascular Scaffolds (BVS) -OPRENBIS Study
Absorb Bioresorbable Vascular Scaffold - Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI)
Absorb Bioresorbable Vascular Scaffold - Safety and Feasibility of Bioabsorbable Everolimus-Eluting Stents for Patients with Internal Pudendal Artery-related Arteriogenic Erectile Dysfunction (PERFECT-ABSORB)
AVJ-09-385 Everolimus Eluting Coronary Stent System - Product Status
AVJ-09-385 Everolimus Eluting Coronary Stent System - Product Description
AVJ-09-385 Everolimus Eluting Coronary Stent System - Spirit Prime Japan (SV JAPAN)
Chemical RDN System - Product Status
Chemical RDN System - Product Description
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects who are at Standard Risk for Carotid Endarterectomy with Significant Extracranial Carotid Stenotic Disease (ACT I)
ESPRIT Bioresorbable Vascular Scaffold - Product Status
ESPRIT Bioresorbable Vascular Scaffold - Product Description
ESPRIT Bioresorbable Vascular Scaffold - A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System for the Treatment of Subjects With Symptomatic Claudication From Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries
Next Generation Mitral Regurgitation System - Product Status
Next Generation Mitral Regurgitation System - Product Description
Next Generation SUPERA Delivery System - Product Status
Next Generation SUPERA Delivery System - Product Description
Xience SBA Everolimus Eluting Coronary Stent System - Product Status
Xience SBA Everolimus Eluting Coronary Stent System - Product Description
XIENCE Thinman DES - Product Status
XIENCE Thinman DES - Product Description
ZoMaxx Drug Eluting Coronary Stent System - Product Status
ZoMaxx Drug Eluting Coronary Stent System - Product Description
Abbott Vascular Inc., Key Employees

LIST OF FIGURES

Abbott Vascular Inc. Pipeline Products by Equipment Type
Abbott Vascular Inc. Pipeline Products by Development Stage
Abbott Vascular Inc. Clinical Trials by Trial Status
Skip to top


Ask Your Question

Abbott Vascular Inc. - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: